WASHINGTON, April 18 (Reuters) - U.S. President Donald Trump signed an executive order on Saturday intended to speed up access to medical research and treatment based on psychedelic ‌drugs. The order ...
President Donald Trump's executive order to accelerate psychedelic drug development has raised hopes among companies ...
President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The ...
President Donald Trump signed an executive order last weekend directing the FDA and other federal agencies to speed research and loosen restrictions on psychedelics, a class of hallucinogenic drugs ...
The executive order notes that more than 14 million American adults now suffer from serious mental illness, a large rise from a decade ago. Trump’s executive order instructs the Food and Drug ...
President Trump recently signed an order to speed up the evaluation of psychedelics to treat the brain. That's coming after decades of strict prohibition on psychedelic drug use dating back to ...
May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate psychedelic drug ⁠development ⁠has raised hopes among companies developing the drugs that it could ⁠help attract more ...